(Two Sessions Express) Zhang Yesui talks about China's international cooperation in the fight against the epidemic: not seeking geopolitical goals
China News Service, Beijing, March 4 (Reporter Xing Chong) Zhang Yesui, spokesperson for the Fourth Session of the 13th National People’s Congress, said in Beijing on the 4th that China’s international anti-epidemic cooperation is not for the pursuit of geopolitical goals, and it never adds Any political conditions.
On the evening of March 4, the press conference of the Fourth Session of the Thirteenth National People's Congress was held in the press conference hall of the Great Hall of the People in Beijing. The spokesperson of the conference Zhang Yesui answered questions from Chinese and foreign journalists on the agenda of the conference and issues related to the work of the National People's Congress.
In order to effectively prevent and control the epidemic and jointly maintain public health and health, the press conference will be conducted in the form of online video.
The picture shows the branch venue.
Photo by China News Agency reporter Jiang Qiming
On the same day, the Fourth Session of the Thirteenth National People's Congress held a press conference in the Press Conference Hall of the Great Hall of the People in Beijing. The spokesperson of the Congress answered questions from Chinese and foreign journalists on the agenda of the Congress and the work-related issues of the National People's Congress.
A reporter asked whether China wants to achieve geopolitical goals through'vaccine diplomacy'.
Zhang Yesui first pointed out that promoting the equitable distribution and use of vaccines around the world, especially ensuring that safe and effective vaccines are available and affordable to developing countries, requires the joint efforts of the international community.
"President Xi Jinping announced at the 73rd World Health Assembly that after the development of China's new crown vaccine is completed and put into use, it will serve as a global public product and make China's contribution to the realization of the vaccine's accessibility and affordability in developing countries." Say.
Zhang Yesui introduced that 17 new crown vaccines in China have entered the clinical trial stage, of which 4 vaccines have been approved by the China National Medical Products Administration for conditional listing, and many vaccines have been approved overseas for phase III clinical trials.
Four Chinese vaccines have obtained emergency use authorizations or conditional marketing approvals from a number of countries.
He said that the Chinese government has provided or is providing free vaccine assistance to more than 60 countries in need.
The Chinese government announced that it will provide 10 million doses of vaccine to the WHO "New Crown Vaccine Implementation Plan" to meet the urgent needs of developing countries.
Zhang Yesui stated that the Chinese government encourages and supports vaccine companies to export vaccines to countries willing to purchase Chinese vaccines.
At present, there are more than 40 countries that have imported or are negotiating to import vaccines from China, most of them are developing countries.
China's National Food and Drug Administration implements strict supervision over the quality of vaccines. Vaccine research and development companies have always strictly followed scientific laws and regulatory requirements to promote vaccine research and development in compliance with laws and regulations.
"In the face of the epidemic, it should be said that nothing is more important than the safety and health of human life." Zhang Yesui emphasized that China's international anti-epidemic cooperation is not to pursue geopolitical goals, nor to attach any political conditions, but to protect more. Human life safety and health.
He said that he hopes that more capable countries will take action to provide vaccines to the international community, especially developing countries, and contribute to international anti-epidemic cooperation.
(Finish)